Publication|Videos|May 13, 2024
At DCAT With Piramal Pharma Solutions
Author(s)Piramal Pharma Solutions
Peter DeYoung, CEO, Piramal Pharma Solutions, talks about recent company achievements and key offerings, as well as current industry trends.
At a recent Drug, Chemical & Associated Technologies (DCAT) conference, Pharmaceutical Technology spoke with Peter DeYoung, CEO, Piramal Pharma Solutions, to learn more about the company's offerings. Watch to learn more about:
- Piramal's key service offerings and integrated solutions in the areas of oncology and ADCs.
- The current operating environment for CDMOs and industry trends.
- Piramal's strategy to expand its territorial footprint in the US beyond its existing facilities.
Related Content
Trending on Pharmaceutical Technology
1
Using Automation to Enhance Pharmaceutical Manufacturing
2
FDA Activity Round Up – July 2026
3
Engineering High-Speed Pen Injector Final Assembly Machine: Solving the Cartridge Press-Fit Challenge
4
Hidden Cost Drivers in Oligonucleotide Manufacturing
5